⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Translational Health Science and Technology Institute (THSTI) and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
THSTI is an autonomous institute of the Department of Biotechnology, Ministry of Science and Technology, Government of India. It is a premier research organization dedicated to integrating medicine, science, engineering, and technology to develop translational knowledge and biomedical innovations that improve public health.
Located in the NCR Biotech Science Cluster in Faridabad, the institute focuses on addressing public health issues of national and global priority. It operates through several intramural centers, including the Vaccine & Infectious Disease Research Centre, Pediatric Biology Centre, and the Clinical Development Services Agency (CDSA), which facilitates large-scale clinical trials and drug development.
CLASSIFICATION
SIZE & FINANCIALS
Employees:201-500
Founded:2009
Ownership:government
Status:operating
PIPELINE
Stage:Discovery
Lead Drug Stage:Preclinical/Phase I
Modalities:Vaccines, Monoclonal Antibodies, Cell therapy, Gene therapy
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Department of Biotechnology, Ministry of Science and Technology, Govt. of India
Key Partnerships:CEPI (Vaccine development), Panacea Biotec (Vaccine manufacturing), Miltenyi Biotec (CAR-T and gene therapy training)
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Prof. Ganesan Karthikeyan - Executive Director
LINKS
Website:thsti.res.in
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Translational Health Science and Technology Institute (THSTI). The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.